Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Queensland Health
Julphar
Fuji
Mallinckrodt
Colorcon
Medtronic
Johnson and Johnson
QuintilesIMS
Teva

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074569

« Back to Dashboard

NDA 074569 describes CLONAZEPAM, which is a drug marketed by Barr, Par Pharm, Sun Pharm Inds Inc, Accord Hlthcare, Actavis Elizabeth, Apotex Inc, Mylan, Mylan Pharms Inc, Prinston Inc, Sandoz, Teva, and Watson Labs, and is included in fifteen NDAs. It is available from forty-seven suppliers. Additional details are available on the CLONAZEPAM profile page.

The generic ingredient in CLONAZEPAM is clonazepam. There are ten drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the clonazepam profile page.
Summary for 074569
Tradename:CLONAZEPAM
Applicant:Teva
Ingredient:clonazepam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 074569
Ingredient-typeBenzodiazepines
Medical Subject Heading (MeSH) Categories for 074569
Suppliers and Packaging for NDA: 074569
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLONAZEPAM clonazepam TABLET;ORAL 074569 ANDA Teva Pharmaceuticals USA, Inc. 0093-0832 N 0093-0832-10
CLONAZEPAM clonazepam TABLET;ORAL 074569 ANDA Teva Pharmaceuticals USA, Inc. 0093-0832 N 0093-0832-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Sep 10, 1996TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Sep 10, 1996TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Sep 10, 1996TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKesson
Deloitte
Citi
US Department of Justice
Daiichi Sankyo
Chubb
Merck
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot